Search Results

Robert L. Ferris, MD, PhD, a head and neck surgical oncologist, leading expert in cancer immunotherapy and cancer center chief executive, has been named the executive director of UNC Lineberger Comprehensive Cancer Center, and UNC system chief of oncology services, effective October 1st, announced UNC School of Medicine Dean Wesley Burks, MD.

Invitae today announced the appointment of W. Michael Korn, M.D., as its chief medical officer for oncology, effective March 13, 2023.

Korn Ferry announced that Kim Crowley has joined the firm as senior client partner and global account leader in the Life Sciences market

Dragonfly Therapeutics, Inc., announced it has expanded its clinical leadership team with the addition of Dr. Robin Edwards, previously Global Head of Translational Sciences at Daiichi Sankyo and Head of Translational at Bristol Myers Squibb, and Dr. David Ferry, previously Head of GI Oncology at Eli Lilly.

Epizyme announced that the Company has granted equity awards to Jerald Korn, the Company’s Chief Operating Officer, with a grant date of April 1, 2022, as equity inducement awards outside of the Company’s 2013 Stock Incentive Plan and material to Mr. Korn’s acceptance of employment with the Company.

Araim Pharmaceuticals, Inc. is pleased to announce the appointment of Ferdinand “Ferry” Breedveld, MD, PhD, the Chairman of the Board at Araim, as the organization’s acting Chief Executive Officer.

CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today that CFO, Bill Korn, will be participating in a virtual panel, “Software for Doctors and Dentists,” at the Healthcare IT Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, July 12, 2022, at 11:00 a.m. EDT.